Kamala Harris

Joe Biden

Dean Phillips

Marianne Williamson

Donald Trump

Vivek Ramaswamy

Nikki Haley

Ron DeSantis

Cornel West

Robert F. Kennedy

2024 United States Presidential Election

Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs).

News Medical

United States

Cellular Origins, Fresenius Kabi sign development agreement for scalable automation of cell and gene therapy manufacturing

Ad Fontes Media

Media Bias/Fact Check

Ian Birkby

Cellular Origins and Fresenius Kabi have signed a development agreement to integrate Fresenius Kabi’s cell therapy processing technologies with Cellular Origins’ CGT robotic manufacturing platform Constellation. The goal is to help cell therapy developers manufacture therapies at scale using preferred processing tools. The initial focus is on integrating Fresenius Kabi’s Cue Cell Processing System for fully automated manufacturing. The collabora…

Dataemia

Aim to integrate Fresenius Kabi’s suite of cell therapy processing technologies within Cellular Origins’ CGT robotic manufacturing platform Constellation.

contractpharma.com

Fresenius Kabi and Cellular Origins Collaborate on CGT Automation

The deal seeks to improve manufacturing efficiency, building upon a busy summer for the TTP subsidiary.

BioProcess International

Cellular Origins and Fresenius Kabi partner to drive automation in CGT manufacturing

Cellular Origins, Fresenius Kabi sign development agreement for scalable automation of cell and gene therapy manufacturing

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics